These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6779482)

  • 21. Iron kinetics in healthy individuals and in chronic renal insufficiency.
    Eschbach JW
    Contrib Nephrol; 1984; 38():129-34. PubMed ID: 6713890
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythropoietin and improvement in the erythropoiesis of chronic hemodialysis patients treated with desferrioxamine.
    de la Serna FJ; Gilsanz F; Praga M; Estenoz J
    Clin Nephrol; 1991 Sep; 36(3):157-8. PubMed ID: 1934678
    [No Abstract]   [Full Text] [Related]  

  • 23. Anemia of chronic renal failure: inhibition of erythropoiesis by uremic serum.
    Freedman MH; Cattran DC; Saunders EF
    Nephron; 1983; 35(1):15-9. PubMed ID: 6888621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietic inhibitors in uremic serum.
    Freedman MH; Grunberger T; Saunders EF
    Clin Invest Med; 1982; 5(4):237-40. PubMed ID: 7160111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of purified erythropoietin with serum proteins.
    Gardner E; Wright CS; Lewis JP; Moores RR
    Br J Haematol; 1967 May; 13(3):317-22. PubMed ID: 6025244
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of inhibitory effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency.
    Pawlak D; Koda M; Wołczyński S; Myśliwiec M; Buczko W
    Adv Exp Med Biol; 2003; 527():375-80. PubMed ID: 15206753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaemia of chronic renal failure; effect of uraemic serum on proliferation and differentiation of stem cells.
    Agarwal S; Mathur M; Deo MG; Sood SK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):371-6. PubMed ID: 548489
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there a dissociation of erythropoietic proliferation and serum erythropoietin levels in renal failure patients on longterm haemodialysis treatment.
    Walle AJ; Niedermayer W
    Proc Eur Dial Transplant Assoc; 1980; 17():162-6. PubMed ID: 7243765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactive erythropoietin and erythropoiesis stimulating factor(s) in plasma from hypertransfused neonatal and adult mice. Studies with a radioimmunoassay and a cell culture assay for erythropoietin.
    Sanengen T; Clemons GK; Halvorsen S; Widness JA
    Acta Physiol Scand; 1989 Jan; 135(1):11-6. PubMed ID: 2643253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of erythropoiesis in uremic patients on CAPD.
    Lamperi S; Carozzi S; Icardi A
    Int J Artif Organs; 1983 Jul; 6(4):191-4. PubMed ID: 6629524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin activity in acutely uremic mice.
    Mirand EA; Gordon AD; Murphy GP
    J Med; 1975; 6(3-4):261-70. PubMed ID: 1059720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of erythropoiesis in chronic uremic patients treated with intermittent hemodialysis.
    Morra L; Ponassi A; Gurreri G; Moccia F; Caristo G; Mela GS; Sacchetti C
    Biomed Pharmacother; 1987; 41(7):396-9. PubMed ID: 3446291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uremic inhibitors of erythropoiesis: a study during treatment with recombinant human erythropoietin.
    Brunati C; Cappellini MD; De Feo T; Guastoni C; Ballerini L; Busnach G; Civati G; Fiorelli G; Minetti L
    Am J Nephrol; 1992; 12(1-2):9-13. PubMed ID: 1415372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of uraemic bone marrow cells to erythropoietin in vitro.
    Urabe A; Chiba S; Kosaka K; Takaku F
    Scand J Haematol; 1976 Nov; 17(5):335-40. PubMed ID: 1006162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin activity in anephric, allotransplanted, unilaterally nephrectomized and intact man.
    Mirand EA; Murphy GP; Steeves RA; Groenewald JM; DeKlerk JN
    J Lab Clin Med; 1969 Jan; 73(1):121-8. PubMed ID: 4883100
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anemia in patients with chronic kidney failure undergoing systematic hemodialysis treatment].
    Landar' VA; Sarycheva TG; Shemetov VD; Kozinets GI
    Urol Nefrol (Mosk); 1989; (1):54-5. PubMed ID: 2718284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin in children with chronic renal failure on dialytic and non-dialytic therapy.
    Aikhionbare HA; Winterborn MW; Gyde OH
    Int J Pediatr Nephrol; 1987; 8(1):9-14. PubMed ID: 3583560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.